Sorry!! The article you are trying to read is not available now.
BioTech/Pharma
Log In
Bussiness News
Politics And Regulation
Markets
The Economy
Editor's Pick
Trading And Investing
Stocks
ETFs
Fixed Income
Currencies
Earnings
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Hoofy & Boo
Radio
From The Buzz & Banter
Daily Recap
MV Education center
Video
t3 live subscriptions
Buzz And Banter
Cooper's Market Report
Techstrat Report
The Options Strategist
Minyanville
All Biotech/pharma Articles
Get
FREE MINYANVILLE
Newsletters & Alerts
Four Closely Watched Drug Decisions Loom in February
By
Brett Chase
Jan 31, 2013 2:45 pm
The month also features a big gathering of biotech CEOs in New York and a cancer research meeting in Florida.
Read this article
Celsion Shares Nosedive After Cancer Therapy Fails
Brett Chase
Isis and Sanofi's Drug OK'd to Treat Inherited Cholesterol Disease
Brett Chase
Keryx Biopharmaceuticals Surges on Prospects for Kidney Drug
Brett Chase
Threshold Pharmaceuticals Rises on Hope for Cancer Drug
Brett Chase
Biogen Idec Aims to Preserve MS Drug Avonex's Sales
Brett Chase
Impax Laboratories' Parkinson's Drug Rejected by FDA
Brett Chase
NuPathe Shares Jump After US Approves Migraine Patch
Brett Chase
GlaxoSmithKline Aims to Compete in Packed Field of Diabetes Drugs
Brett Chase
Johnson & Johnson Diabetes Drug Endorsed by Review Panel
Brett Chase
Teva Aims to Derail Approval of Biogen Idec's MS Pill
Brett Chase
Idenix Says FDA Needs More Time to Review Hold on Hepatitis C Drug
Brett Chase
Johnson & Johnson Diabetes Medicine Faces Big Test
Brett Chase
Celgene Rises After CEO Hugin Touts New Drugs, Sales Growth
Brett Chase
Which Abbott Shares Should You Keep?
MoneyShow.com
X Factor: 5 Stocks Reaching Their Ex-Dividend Date on January 11
Christopher Witrak
Biogen Idec's Drug for Rare Disease Fails in Study
Brett Chase
Biogen and PowerShares QQQ Trust Among Most Active Stocks in Nasdaq Pre-Market
Christopher Witrak
Recommendations
Archive
March, 2018
February, 2018
January, 2018
December, 2017
November, 2017
October, 2017
September, 2017
August, 2017
July, 2017
June, 2017
May, 2017
April, 2017
TICKERS
PFE
MRK
JNJ
BMY
GSK
DNDN
GILD
VRTX
AMGN
LLY
ARNA
BIIB
See All Tickers »